Inventor · disambiguated record
Bradley John Hedberg
Also filed as: HEDBERG BRADLEY · HEDBERG BRADLEY J · HEDBERG BRADLEY JOHN
9 granted patents·1 pending application·40 citations·filing 2008–2023
84Inventor score
Files withCENTRE FOR DRUG RES AND DEVELOPMENT3ZYMEWORKS INC3ZYMEWORKS BC INC2BARRY SIMON THOMAS1THE CENTRE FOR DRUG RES AND DEV1
Top patents by PatentIndex Score
10 records- 0195US9522876B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS INC·Filed 2014·Granted Dec 20, 2016·19 cites·48 claims
- 0285US8119130B2Targeted binding agents directed to KDR and uses thereof—035BARRY SIMON THOMAS·Filed 2008·Granted Feb 21, 2012·14 cites·4 claims
- 0383US10201614B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS INC·Filed 2014·Granted Feb 12, 2019·3 cites·38 claims
- 0482US12303544B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS BC INC·Filed 2023·Granted May 20, 2025·0 cites·24 claims
- 0577US11390673B2Anti-podocalyxin antibodies and methods of using the sameCENTRE FOR DRUG RES AND DEVELOPMENT·Filed 2019·Granted Jul 19, 2022·2 cites·17 claims
- 0676US11090383B2Anti-podocalyxin antibodies and methods of using the sameCENTRE FOR DRUG RES AND DEVELOPMENT·Filed 2016·Granted Aug 17, 2021·2 cites·18 claims
- 0772US11617777B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS BC INC·Filed 2019·Granted Apr 4, 2023·0 cites·23 claims
- 0856US12053524B2Anti-podocalyxin antibodies and methods of using the sameCENTRE FOR DRUG RES AND DEVELOPMENT·Filed 2021·Granted Aug 6, 2024·0 cites·17 claims
- 0952US10675355B2VAR2CSA-drug conjugatesZYMEWORKS INC·Filed 2014·Granted Jun 9, 2020·0 cites·43 claims
- 1050US2016264663A1Anti-podocalyxin antibodies and methods of using the sameTHE CENTRE FOR DRUG RES AND DEV·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bradley John Hedberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →